OVB

Hydrogel Spacer

Product code
OVB
Device name
Hydrogel Spacer
Device class
Class 2
21 CFR
21 CFR 892.5725
Medical specialty
Radiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
7 (all years; only the last 3 years are listed here)

FDA classification definition

The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-02-10.

NumberDecision dateApplicantDevice nameSummary
K2601192026-02-10Boston Scientific CorporationSpaceOAR Vue System (SV-2101)PDF

1 summaries are archived here for direct download.

Official FDA classification page: OVB
Classification and pathway per current FDA publications. Data from openFDA (CC0).